中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 1
Jan.  2018
Turn off MathJax
Article Contents

The natural history and clinical features of nonalcoholic fatty liver disease-related cirrhosis

DOI: 10.3969/j.issn.1001-5256.2018.01.004
  • Published Date: 2018-01-20
  • Nonalcoholic fatty liver disease ( NAFLD) is a type of metabolic liver injury closely associated with insulin resistance and genetic susceptibility and includes nonalcoholic simple fatty liver, nonalcoholic steatohepatitis, liver cirrhosis, and hepatocellular carcinoma. It has become an important public health issue nowadays. This article elaborates on the unique natural history of NAFLD and the clinical features of NAFLD-related cirrhosis. Further research on the progression of NAFLD-related cirrhosis is needed in the future to prevent the progression to liver cirrhosis, reduce liver-related death events, and relieve the economic burden for public health.

     

  • loading
  • [1]LINDENMEYER CC, Mc CULLOUGH AJ.The natural history of nonalcoholic fatty liver disease-an evolving view[J].Clin Liver Dis, 2018, 22 (1) :11-21.
    [2]FAN JG, ZHU J, LI XJ, et al.Prevalence of and risk factors for fatty liver in a general population of Shanghai, China[J].J Hepatol, 2005, 43 (3) :508-514.
    [3]HASHIMOTO E, TANIAI M, TOKUSHIGE K.Characteristics and diagnosis of NAFLD/NASH[J].J Gastroenterol Hepatol, 2013, 28 (Suppl 4) :64-70.
    [4]THAN NN, NEWSOME PN.A concise review of non-alcoholic fatty liver disease[J].Atherosclerosis, 2015, 239 (1) :192-202.
    [5]SWEET PH, KHOO T, NGUYEN S.Nonalcoholic fatty liver disease[J].Prim Care, 2017, 44 (4) :599-607.
    [6]ARGO CK, NORTHUP PG, AL-OSAIMI AM, et al.Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis[J].J Hepatol, 2009, 51 (2) :371-379.
    [7]ANGULO P.Long-term mortality in nonalcoholic fatty liver disease:is liver histology of any prognostic significance?[J].Hepatology, 2010, 51 (2) :373-375.
    [8]STANKOVIC'MN, MLADENOVIC'DR, DURICˇIC'I, et al.Time-dependent changes and association between liver free fatty acids, serum lipid profile and histological features in mice model of nonalcoholic fatty liver disease[J].Arch Med Res, 2014, 45 (2) :116-124.
    [9]CHENG JY, WONG VW, TSE YK, et al.Metabolic syndrome increases cardiovascular events but not hepatic events and death in patients with chronic hepatitis B[J].Hepatology, 2016, 64 (5) :1507-1517.
    [10]DAM-LARSEN S, BECKER U, FRANZMANN MB, et al.Final results of a long-term, clinical follow-up in fatty liver patients[J].Scand J Gastroenterol, 2009, 44 (10) :1236-1243.
    [11]TILG H, MOSCHEN AR.Evolution of inflammation in nonalcoholic fatty liver disease:the multiple parallel hits hypothesis[J].Hepatology, 2010, 52 (5) :1836-1846.
    [12]TREEPRASERTSUK S, LOPEZ-JIMENEZ F, LINDOR KD.Nonalcoholic fatty liver disease and the coronary artery disease[J].Dig Dis Sci, 2011, 56 (1) :35-45.
    [13]DAY CP, JAMES OF.Steatohepatitis:a tale of two"hits"?[J].Gastroenterology, 1998, 114 (4) :842-845.
    [14]PAPPACHAN JM, BABU S, KRISHNAN B, et al.Non-alcoholic fatty liver disease:a clinical update[J].J Clin Transl Hepatol, 2017, 5 (4) :384-393.
    [15]SANYAL AJ, American Gastroenterological Association.AGA technical review on nonalcoholic fatty liver disease[J].Gastroenterology, 2002, 123 (5) :1705-1725.
    [16]CHALASANI N, YOUNOSSI Z, LAVINE JE, et al.The diagnosis and management of non-alcoholic fatty liver disease:practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association[J].Hepatology, 2012, 55 (6) :2005-2023.
    [17]SCHINDHELM RK, HEINE RJ, DIAMANT M.Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients[J].Diabetes Care, 2007, 30 (9) :e94.
    [18]REID AE.Nonalcoholic steatohepatitis[J].Gastroenterology, 2001, 121 (3) :710-723.
    [19]TSAI E, LEE TP.Diagnosis and evaluation of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis, including noninvasive biomarkers and transient elastography[J].Clin Liver Dis, 2018, 22 (1) :73-92.
    [20]TAKEUCHI H, SUGIMOTO K, OSHIRO H, et al.Liver fibrosis:noninvasive assessment using supersonic shear imaging and FIB4 index in patients with non-alcoholic fatty liver disease[J].J Med Ultrason (2001) , 2017.[Epub ahead of print]
    [21]HWANG YC, AHN HY, PARK SW, et al.Non-alcoholic fatty liver disease associates with increased overall mortality and death from cancer, cardiovascular disease, and liver disease in women but not men[J].Clin Gastroenterol Hepatol, 2017.[Epub ahead of print]
    [22]TASNEEM AA, LUCK NH, MAJID Z.Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) [J].Trop Doct, 2017.[Epub ahead of print]
    [23]HASHIMOTO E, YATSUJI S, TOBARI M, et al.Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis[J].J Gastroenterol, 2009, 44 (Suppl 19) :89-95.
    [24]VILAR-GOMEZ E, CHALASANI N.Noninvasive assessment of nonalcoholic fatty liver disease:clinical prediction rules and blood based biomarkers[J].J Hepatol, 2017.[Epub ahead of print]
    [25]YATSUJI S, HASHIMOTO E, TOBARI M, et al.Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C[J].J Gastroenterol Hepatol, 2009, 24 (2) :248-254.
    [26]BYRNE CD, TARGHER G.NAFLD:a multisystem disease[J].J Hepatol, 2015, 62 (1 Suppl) :s47-s64.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2524) PDF downloads(488) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return